Evidence map›Paper›PMID 29108253›Full record

ArticleOncotarget2017

Identification of LRP-1 as an endocytosis and recycling receptor for β1-integrin in thyroid cancer cells.

Louis Theret, Albin Jeanne, Benoit Langlois, Cathy Hachet, Marion David, Michel Khrestchatisky, Jérôme Devy, Emonard Hervé, Sébastien Almagro, Stéphane Dedieu

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Louis TheretUniversité de Reims Champagne-Ardenne, UFR Sciences Exactes et Naturelles, Reims, France.
Albin JeanneUniversité de Reims Champagne-Ardenne, UFR Sciences Exactes et Naturelles, Reims, France.
Benoit LangloisUniversité de Reims Champagne-Ardenne, UFR Sciences Exactes et Naturelles, Reims, France.
Cathy HachetUniversité de Reims Champagne-Ardenne, UFR Sciences Exactes et Naturelles, Reims, France.
Marion DavidVECT-HORUS SAS, Faculté de Médecine Secteur Nord, Marseille, France.
Michel KhrestchatiskyAix Marseille Université, CNRS, NICN, Marseille, France.
Jérôme DevyUniversité de Reims Champagne-Ardenne, UFR Sciences Exactes et Naturelles, Reims, France.
Emonard HervéUniversité de Reims Champagne-Ardenne, UFR Sciences Exactes et Naturelles, Reims, France.
Sébastien AlmagroUniversité de Reims Champagne-Ardenne, UFR Sciences Exactes et Naturelles, Reims, France.
Stéphane DedieuUniversité de Reims Champagne-Ardenne, UFR Sciences Exactes et Naturelles, Reims, France.
Centre National de la Recherche Scientifique · FRInstitut de Neurophysiopathologie · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

LRP-1 is a large endocytic receptor mediating the clearance of various molecules from the extracellular matrix. LRP-1 was reported to control focal adhesion turnover to optimize the adhesion-deadhesion balance to support invasion. To better understand how LRP-1 coordinates cell-extracellular matrix interface, we explored its ability to regulate cell surface integrins in thyroid carcinomas. Using an antibody approach, we demonstrated that β1-integrin levels were increased at the plasma membrane under

Indexed as

cancerendocytosisLRP-1recyclingβ1-integrin

Identifiers

PMID29108253
PMCPMC5667986
OpenAlexW2743046540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.